Navigation Links
ChromaDex® Announces Management Changes
Date:2/17/2012

IRVINE, Calif., Feb. 17, 2012 /PRNewswire/ -- ChromaDex Corporation (OTCBB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries and marketer of BluScience™ (www.bluscience.com), its recently launched line of dietary supplements, announced today that William F. Spengler has elected to step down from his positions of President and Director of ChromaDex to pursue other business interests. It is anticipated that Jeffrey Himmel, who was recently appointed as CEO of ChromaDex, will also assume the role and title of President.

(Logo:  http://photos.prnewswire.com/prnh/20110830/LA59283LOGO)

Commenting on the announcement, Mr. Spengler stated, "With the company's business plan unfolding nicely and a successful round of equity financing recently completed, ChromaDex is now well positioned for sustained growth. I believe that the company has a bright future ahead of it."

Frank Jaksch, ChromaDex Founder and Chief Science Officer commented, "On behalf of the Board and our employees, I want to thank Bill for his many contributions to the company. All of us at ChromaDex wish him great success in his future endeavors."

About ChromaDex®:
ChromaDex, Inc. is an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries. The company has an expanding pipeline of new ingredients, including its pTeroPure® (www.pteropure.com) pterostilbene for which it has worldwide, exclusive patent pending rights. The company recently launched its BluScience™ line of dietary supplements. Capitalizing on the diverse potential applications of the product, ChromaDex is also developing pTeroPure for the skincare and pharmaceutical markets, among others. pTeroPure is currently being studied in a human clinical trial at the University of Mississippi.

For more information about pTeroPure, visit www.pteropure.com or call 949-600-9694.

Forward-Looking Statements:
Any statements that are not historical facts contained in this release are "forward-looking statements" as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These factors include those described in the companies' filings with the Securities and Exchange Commission, and risks inherent in funding, developing and obtaining regulatory approvals of new, commercially-viable and competitive products and treatments. In addition, forward-looking statements may also be adversely affected by general market factors, competitive product development, product availability, federal and state regulations and legislation, the regulatory process for new products and indications, manufacturing issues that may arise, patent positions and litigation, among other factors. The forward-looking statements contained in this press release speak only as of the date the statements were made, and the companies do not undertake any obligation to update forward-looking statements. We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA.

ChromaDex Investor Contact:
Liviakis Financial Communications, Inc.
John M. Liviakis, President                                                   
415-389-4670
John@Liviakis.com

Institutions and Analysts Contact:
The Del Mar Consulting Group, Inc.
Robert B. Prag, President
858-794-9500
bprag@delmarconsulting.com

ChromaDex/BluScience Contact:
Jeffrey Himmel, CEO
949-419-0288
jsh@chromadex.com


'/>"/>
SOURCE ChromaDex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. ChromaDex® Expands National Launch of its BluScience™ Line of Dietary Supplements Through McKesson
2. NIAID announces 25 new awards to develop radiation countermeasures
3. Aware Announces Q3 2008 Earnings Conference Call
4. Governor Doyle announces historic genomic research collaboration
5. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
6. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
7. Parkinsons Disease Foundation announces award of $150,000
8. Jefferson Department of Surgery announces new pancreas tumor registry
9. NAS announces initiative to connect entertainment industry with top experts
10. Elsevier announces winners of 3rd Annual Scopus Young Indian Scientist Award
11. VUANCE Announces Crime Scene Security and Evidentiary Tracking Development Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2017)... MATEO, Calif. , March 6, 2017 /PRNewswire/ ... marketing and sales technology, today announced Predictive Sales ... solution for infusing actionable sales intelligence into Salesforce. ... to automatically enable their sales organizations with deep ... messages that allow for intelligent engagement. Predictive Sales ...
(Date:3/2/2017)... Summary This report provides all the information ... partnering interests and activities since 2010. Download the ... Deals and Alliance since 2010 report provides an in-depth ... world,s leading life sciences companies. On demand ... of the most up to date deal and company ...
(Date:3/2/2017)... , March 2, 2017 Australian stem ... (ASX: CYP), has signed an agreement with the ... the Monash Biomedicine Discovery Institute and Department of Pharmacology ... conduct a further preclinical study to support the use ... of asthma.  Asthma is a chronic, ...
Breaking Biology News(10 mins):
(Date:3/29/2017)... ... , ... Bactana Animal Health, a company developing natural products aimed at reducing ... the gut microbiota, today announced the closing of its first round of funding. ... Capital Management, LLC and a number of private investors. The company will use the ...
(Date:3/29/2017)... NEWARK, Del. , March 29, 2017 ... medicine company, and W. L. Gore & ... announced a collaborative research agreement whereby the two companies ... delivery device technologies that provide protection from immune rejection. ... has been developing innovative stem cell-derived cell replacement therapies ...
(Date:3/29/2017)... TORONTO , March 29, 2017 /PRNewswire/ -  GeneNews Limited ... of BreastSentry™ , a new risk stratification test for ... reference lab, Innovative Diagnostics Laboratory ("IDL"). BreastSentry incorporates a blood-based ... five-year and lifetime risk for developing breast cancer.   ... BreastSentry measures ...
(Date:3/29/2017)... The Global Microfluidic Chips Market by Manufacturers, Countries, Type ... study on the existing state of the global Microfluidic Chips industry ... and Asia-Pacific , South ... Africa . ... Browse 172 Tables and Figures, 13 Major Company Profiles, spread ...
Breaking Biology Technology: